Markets
Stocks
Mutual Funds & ETFs
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Gilead Sciences, Inc. (NQ: GILD)
75.19 USD  +1.20 (+1.62%)
Official Closing Price  /  Updated: 4:30 PM EST, Dec 9, 2013  /  Add to My Watchlist      
View: Quote Chart Options News SEC Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 17,245,824
Open 76.00
Bid (Size) 75.19 (14500)
Ask (Size) 75.20 (600)
Prev. Close 73.99
Today's Range 74.23 - 76.11
52wk Range 35.68 - 75.43
Shares Outstanding 1,533,349,106
Dividend Yield N/A
Performance
YTD
+0.17%
+0.17%
1 Month
+14.57%
+14.57%
3 Month
+20.00%
+20.00%
6 Month
+43.38%
+43.38%
1 Year
+1.72%
+1.72%
Featured News
More News
Bullish Breakout Boosts Target for Top Biotech
September 19, 2013
Gilead Sciences (GILD) blasted through resistance from a "V" formation. The post Bullish Breakout Boosts Target for Top Biotech appeared first on InvestorPlace . Read More
category Stocks to Buy , NASDAQ:GILD , Trading Advice
from InvestorPlace » Stock Picks
4 Healthcare Investments to Make Before October
September 10, 2013
With open enrollment in state health insurance exchanges set to kick off on Oct. 1, it’s a good time to revisit the ways investors can play the opportunity. The post 4 Healthcare Investments to Make... Read More
category MUTF:FSPHX , Stocks to Buy , NASDAQ:GILD , and 3 more.
from InvestorPlace » Stock Picks
Featured News
Read More
Top 6 Stocks to Buy for September
September 03, 2013
category NYSE:D , NYSE:OKE , Stocks to Buy , and 3 more.
from InvestorPlace » Stock Picks
More News
Read More
Interest Stock Analysis: Gilead Sciences, Acura Pharmaceuticals, Barnes & Noble, Micron Technology
Today 14:00 EST
from ACCESSWIRE
La Administración de Medicamentos y Alimentos de Estados Unidos aprueba Sovaldi™ (sofosbuvir) de Gilead para el tratamiento de la hepatitis C crónica
Today 9:36 EST
from Business Wire Spanish
Gilead anuncia los datos de fase 2 fundamentales para idelalisib en el linfoma no-Hodgkin indolente refractario
Today 9:25 EST
from Business Wire Spanish
Gilead anuncia resultados provisionales de Fase 2 de GS-9973 en leucemia linfocítica crónica tratada con anterioridad
Today 9:15 EST
from Business Wire Spanish
Moody's Boosts Outlook on Gilead Sciences (GILD) to Positive; Ratings Affirmed
Today 14:53 EST
from StreetInsider.com News Articles
Notable 52-Week Highs and Lows of the Day 12/09: (MU) (PRAN) (GILD) High; (OSIS) (EW) (EZPW) Low
Today 14:07 EST
from StreetInsider.com News Articles
Midday movers: McDonald's, Dean Foods & more
Today 11:39 EST
category Economics , Investing/Investment Strategy , Economics/Consumers , and 13 more.
from CNBC.com News
20.3% Return Seen to Date on SmarTrend Gilead Sciences Call (GILD)
Today 11:17 EST
from Comtex SmarTrend® News Briefs
Gilead Sciences (GILD) gains on leukemia test data
Today 10:11 EST
from BAYSTREET RSS FEED
Benzinga's Top #PreMarket Gainers
Today 8:08 EST
category Benzinga , US1510201049 , US00509L7038 , and 13 more.
from Latest Articles from Benzinga.com
Idenix Pharma (IDIX) Reports HCV Treatment Patent Interference (GILD)
Today 8:05 EST
from StreetInsider.com News Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here